.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
US Department of Justice
Accenture
Boehringer Ingelheim
Citi
Baxter
Dow
Express Scripts
Covington

Generated: September 26, 2017

DrugPatentWatch Database Preview

Oxytetracycline calcium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for oxytetracycline calcium and what is the scope of oxytetracycline calcium patent protection?

Oxytetracycline calcium
is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for oxytetracycline calcium.

Summary for Generic Name: oxytetracycline calcium

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list36
Bulk Api Vendors: see list54
Clinical Trials: see list1,775
Patent Applications: see list11,653
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxytetracycline calcium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
TERRAMYCIN
oxytetracycline calcium
SYRUP;ORAL060595-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Medtronic
Queensland Health
Cerilliant
Moodys
QuintilesIMS
Novartis
Farmers Insurance
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot